• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

130.36 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Wednesday's session: top gainers and losers in the dow jones index ↗
July 29, 2026
Via Chartmill
News headline image
Merck Announces Fourth-Quarter 2026 Dividend
July 29, 2026
From Merck & Co., Inc.
Via Business Wire
Uncover the latest developments among dow jones stocks in today's session. ↗
July 28, 2026
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
July 28, 2026
Via Chartmill
Monday's session: top gainers and losers in the dow jones index ↗
July 27, 2026
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
July 24, 2026
Via Chartmill
News headline image
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
July 24, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗
July 24, 2026
There are plenty of reasons to love these companies. 
Via The Motley Fool
News headline image
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer ↗
July 23, 2026
Income seekers shouldn't give up on the stock yet. 
Via The Motley Fool
These dow jones stocks are moving in today's session ↗
July 23, 2026
Via Chartmill
What's going on in today's session: dow jones movers ↗
July 23, 2026
Via Chartmill
News headline image
1 Dow Jones Stock with Exciting Potential and 2 Facing Headwinds
July 23, 2026
While the Dow Jones (^DJI) represents industry leaders, not every stock in the index is a safe bet. Some are facing headwinds like declining demand, rising c... 
Via StockStory
Topics Artificial Intelligence Stocks
These dow jones stocks are moving in today's session ↗
July 22, 2026
Via Chartmill
Stay informed with the top movers within the dow jones index on Tuesday. ↗
July 21, 2026
Via Chartmill
Which dow jones stocks are moving on Tuesday? ↗
July 21, 2026
Via Chartmill
News headline image
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
July 21, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)
July 20, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Stay informed with the top movers within the dow jones index on Monday. ↗
July 20, 2026
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
July 20, 2026
Via Chartmill
These dow jones stocks are moving in today's session ↗
July 17, 2026
Via Chartmill
Top dow jones movers in Friday's session ↗
July 17, 2026
Via Chartmill
Which dow jones stocks are moving on Thursday? ↗
July 16, 2026
Via Chartmill
News headline image
Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
July 16, 2026
From Merck & Co., Inc.
Via Business Wire
What's going on in today's session: dow jones movers ↗
July 15, 2026
Via Chartmill
Stay informed with the top movers within the dow jones index on Wednesday. ↗
July 15, 2026
Via Chartmill
Get insights into the top movers in the S&P500 index of Wednesday's pre-market session. ↗
July 15, 2026
Via Chartmill
News headline image
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
July 15, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
July 15, 2026
From Merck & Co., Inc.
Via Business Wire
Top dow jones movers in Tuesday's session ↗
July 14, 2026
Via Chartmill
Top dow jones movers in Friday's session ↗
July 10, 2026
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap